CD44 and cancer: Antibodies (mAbs) to CD44 are being investigated for cancer therapy [159], for example, mAb U36 specific to CD44v6 in HNSCC [160] and mAb VFF18 specific to CD44v6 in human squamous cell carcinomas [161].